Overview

Liver Transplant European Study Into the Prevention of Fungal Infection

Status:
Completed
Trial end date:
2012-05-03
Target enrollment:
Participant gender:
Summary
Prevention of invasive fungal infection in high risk patients following liver transplant.
Phase:
Phase 3
Details
Lead Sponsor:
Astellas Pharma Inc
Treatments:
Amphotericin B
Caspofungin
Echinocandins
Fluconazole
Liposomal amphotericin B
Micafungin